FOXP3 and autoimmune disease: Previous studies have observed significant reductions in Foxp3 expression and/or Treg function in several human autoimmune diseases, including multiple sclerosis (MS), myasthenia gravis, and type I diabetes [17], [19], suggesting that defects in Foxp3 expression and/or Treg function may precipitate the loss of immunological tolerance.